Note: This section contains information in English only.Johnson & Johnson will unlikely to meet the US COVID-19 vaccine supply target by spring, as the company faces delays in vaccine production, according to the New York Times report seen on Wednesday.
Wed, 13 Jan 2021 14:46:53 GMT
Source: Dukascopy Bank SA